MRPS33P4: A Potential Drug Target and Biomarker for Mitochondrial Ribosomal Protein S33 Pseudogene 4

MRPS33P4: A Potential Drug Target and Biomarker for Mitochondrial Ribosomal Protein S33 Pseudogene 4

Abstract:

Mitochondrial ribosomal protein S33 pseudogene 4 (MRPS33P4) is a gene that encodes a protein essential for mitochondrial function. The protein functions as a subunit of the large ribosomal subunit, which is responsible for protein synthesis in the mitochondria. In addition to its function in protein synthesis, MRPS33P4 has also been implicated in the regulation of mitochondrial dynamics and the development of certain diseases. As a result, targeting MRPS33P4 may provide new insights into the pathophysiology of these diseases and serve as a potential drug target.

Introduction:

Mitochondria are organelles that are responsible for generating the majority of the energy for the cell in the form of ATP. They are also involved in the regulation of various cellular processes, including metabolism, stress response, and disease development. The mitochondria possess a complex system of genes that are involved in the regulation of their structure and function. One of these genes, MRPS33P4, has been identified as a potential drug target and biomarker for various diseases.

History of MRPS33P4:

The gene encoding MRPS33P4 was first identified in 1995 using DNA sequencing. It is a member of the large ribosomal subunit A gene family, which is responsible for the synthesis of proteins that form the largest subunit of the ribosome. In addition to its function in protein synthesis, MRPS33P4 has also been shown to play a role in the regulation of mitochondrial dynamics and the development of certain diseases.

Functional characterization of MRPS33P4:

MRPS33P4 is a 21-kDa protein that is expressed in the mitochondria. It is highly conserved and has a similar structure to other ribosomal proteins. It is composed of a unique N-terminus that contains a farnesylated cysteine residue, which is important for its stability and localization in the mitochondria. The middle region of the protein contains a Rossmann-fold, which is a common structural motif found in ribosomal proteins. The C-terminus of MRPS33P4 contains a GFP-labeled domain that is involved in the regulation of mitochondrial dynamics.

MRPS33P4 has been shown to play a role in the regulation of mitochondrial dynamics by affecting the stability and localization of its N-terminus. Studies have shown that farnesylated cysteine residues, such as the one found in MRPS33P4, are critical for the stability and localization of the protein in the mitochondria. In addition, studies have shown that the Rossmann-fold is involved in the formation of a distinct localization domain in the middle region of the protein.

MRPS33P4 has also been shown to be involved in the regulation of mitochondrial function by affecting the structure and function of the mitochondria. Studies have shown that the protein is involved in the regulation of mitochondrial cytoskeleton formation and that it plays a role in the regulation of mitochondrial dynamics. In addition, studies have shown that the protein is involved in the regulation of mitochondrial translation efficiency, which is the rate at which proteins are synthesized from mRNA in the mitochondria.

Disease association with MRPS33P4:

The gene encoding MRPS33P4 has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. This is because the protein functions

Protein Name: Mitochondrial Ribosomal Protein S33 Pseudogene 4

The "MRPS33P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS33P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MRPS34 | MRPS35 | MRPS35-DT | MRPS36 | MRPS36P4 | MRPS5 | MRPS6 | MRPS7 | MRPS9 | MRRF | MRS2 | MRS2P2 | MRTFA | MRTFB | MRTO4 | MS4A1 | MS4A10 | MS4A12 | MS4A13 | MS4A14 | MS4A15 | MS4A18 | MS4A2 | MS4A3 | MS4A4A | MS4A4E | MS4A5 | MS4A6A | MS4A6E | MS4A7 | MS4A8 | MSANTD1 | MSANTD2 | MSANTD3 | MSANTD4 | MSC | MSC-AS1 | MSGN1 | MSH2 | MSH3 | MSH4 | MSH5 | MSH5-SAPCD1 | MSH6 | MSI1 | MSI2 | MSL1 | MSL2 | MSL3 | MSL3P1 | MSLN | MSLNL | MSMB | MSMO1 | MSMP | MSN | MSNP1 | MSR1 | MSRA | MSRA-DT | MSRB1 | MSRB1P1 | MSRB2 | MSRB3 | MSRB3-AS1 | MSS51 | MST1 | MST1L | MST1P2 | MST1R | MSTN | MSTO1 | MSTO2P | MSX1 | MSX2 | MSX2P1 | MT1A | MT1B | MT1DP | MT1E | MT1F | MT1G | MT1H | MT1HL1 | MT1IP | MT1JP | MT1L | MT1M | MT1P1 | MT1P3 | MT1X | MT1XP1 | MT2A | MT3 | MT4 | MTA1 | MTA1-DT | MTA2 | MTA3 | MTAP